Details for Patent: 8,309,122
✉ Email this page to a colleague
Summary for Patent: 8,309,122
| Title: | Oxymorphone controlled release formulations |
| Abstract: | The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24 hours after dosing, as well as the tablet producing the sustained pain relief. |
| Inventor(s): | Kao; Huai-Hung (Syosset, NY), Baichwal; Anand R. (Wappingers Falls, NY), McCall; Troy (Smyma, GA), Lee; David (Chadds Ford, PA) |
| Assignee: | Endo Pharmaceuticals Inc. (Chadds Ford, PA) |
| Application Number: | 11/680,432 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,309,122 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Dosage form; Delivery; Use; |
Drugs Protected by US Patent 8,309,122
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,309,122
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 359077 | ⤷ Sign Up | |||
| Austria | 376832 | ⤷ Sign Up | |||
| Australia | 2002316582 | ⤷ Sign Up | |||
| Australia | 2002318211 | ⤷ Sign Up | |||
| Australia | 2002320309 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
